Working at the interface of engineering and hematology, the Neeves Lab is interested in how flows and forces regulate blood clot formation and dissolution.
The lab conducts mechanistic studies and develops diagnostics and drug delivery technologies. This approach is used to predict modifiers in bleeding risk and response to therapy in individuals with genetic disorders. They work collaboratively with the Hemophilia & Thrombosis Center at the CU School of Medicine and the Center for Cancer and Blood Disorders at Children’s Hospital Colorado.
Our lab has developed magnetically powered microbots for chemically and mechanically ablating clots in the brain to reestablish blood flow in ischemic stroke.